Peer Review reports
From: FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway
Original Submission | ||
---|---|---|
30 Oct 2018 | Submitted | Original manuscript |
2 Jan 2019 | Reviewed | Reviewer Report - Xiangmin Tong |
13 Feb 2019 | Reviewed | Reviewer Report - Reviewer 2 |
23 Apr 2019 | Author responded | Author comments - Xiaorong Liu |
Resubmission - Version 2 | ||
23 Apr 2019 | Submitted | Manuscript version 2 |
8 May 2019 | Reviewed | Reviewer Report - Reviewer 2 |
14 Jun 2019 | Reviewed | Reviewer Report - Reviewer 3 |
25 Jun 2019 | Author responded | Author comments - Xiaorong Liu |
Resubmission - Version 3 | ||
25 Jun 2019 | Submitted | Manuscript version 3 |
27 Jun 2019 | Author responded | Author comments - Xiaorong Liu |
Resubmission - Version 4 | ||
27 Jun 2019 | Submitted | Manuscript version 4 |
Publishing | ||
2 Jul 2019 | Editorially accepted | |
10 Jul 2019 | Article published | 10.1186/s12885-019-5898-4 |
You can find further information about peer review here.